Publication | Closed Access

Target identification, lead optimization and antitumor evaluation of some new 1,2,4-triazines as c-Met kinase inhibitors

Medicinal ChemistryDrug TargetMedicineTarget IdentificationRational Drug DesignPharmacotherapyAnti-cancer AgentDrug DevelopmentC-met Kinase InhibitorsPharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryLead Optimization